Is replacement of the external recharging system for a spinal cord stimulator (SCS) battery approved for a patient with Complex Regional Pain Syndrome (CRPS) of the left foot, back pain, lumbar disc disease, and a history of falls, who is currently experiencing back spasms and has a previously implanted SCS system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approval of External Recharging System Replacement for Spinal Cord Stimulator

The replacement of the external recharging system (precision charging system) for this patient's spinal cord stimulator should be approved as medically necessary, and the device may be obtained from a medical equipment provider. 1

Medical Necessity Justification

Generator/charging system replacement is medically necessary when the existing device requires more frequent charging and the patient has demonstrated positive pain relief response from the existing system. 1 This patient meets these criteria with:

  • Established long-term efficacy: Previously implanted spinal cord stimulator system providing pain control for CRPS and back pain 1
  • Clinical deterioration: Current presentation with back spasms and multiple falls suggests inadequate pain control, likely related to charging system failure 1
  • Appropriate diagnosis: CRPS of the left foot with chronic neuropathic pain and radicular symptoms (back pain/lumbar disc disease) are established indications for spinal cord stimulation 2, 3

Device Specifications and Standard of Care

The precision charging system requested represents standard equipment rather than an upgrade beyond medical necessity. 1 Key considerations include:

  • Rechargeable systems are standard of care: They reduce replacement surgeries, overall costs, and therapy-related morbidity compared to non-rechargeable systems 4
  • Charging frequency impacts outcomes: Patients typically recharge 5.2 times per month for 2.3 hours each session, with 23.3% of recharging attempts being problematic 4
  • Battery optimization is critical: Proper charging systems can extend battery life 2.2-fold (29.6 months improvement on average), significantly delaying surgical replacement 5

Safety and Quality of Life Considerations

The patient's history of multiple falls creates urgent medical necessity for optimal device function. 1 Falls in patients with chronic pain and spinal cord stimulators represent significant morbidity risk:

  • Infection risk with device complications: Device extrusion and other complications can occur, particularly with mechanical stress 6
  • Functional decline prevention: Pain relief facilitates participation in functional therapies to normalize use and improve motion, strength, and dexterity 2
  • Fall prevention: Adequate pain control through properly functioning neuromodulation reduces fall risk in this vulnerable population 7

Procurement Source

The external recharging system may appropriately be obtained from a medical equipment provider rather than requiring hospital-based procurement. 1 This is standard practice for external components of implanted neuromodulation systems, as these are durable medical equipment items that interface with but are not surgically implanted components.

Clinical Caveats

Monitor for charging system complications: Great variability exists in length, frequency, and ease of recharging, with these factors determining patient satisfaction and compliance 4. If the patient experiences ongoing difficulties with the new charging system (>23% failed charging attempts), reassessment may be needed 4.

Ensure voltage compliance matching: The new charging system's voltage compliance must match the existing electrode impedance to maintain therapeutic efficacy 1. This technical requirement should be verified by the medical equipment provider before dispensing.

References

Guideline

Medical Necessity Determination for Spinal Cord Stimulator Generator Replacement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Complex Regional Pain Syndrome.

Current treatment options in neurology, 2003

Research

Patient perspectives on the efficacy and ergonomics of rechargeable spinal cord stimulators.

Neuromodulation : journal of the International Neuromodulation Society, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the recommended shoes for Complex Regional Pain Syndrome (CRPS)?
What is the life expectancy of patients with Complex Regional Pain Syndrome (CRPS)?
Is replacement of a spinal cord stimulator or battery/generator medically necessary for a patient with a history of positive response to the existing stimulator and an expired battery that is no longer under warranty and cannot be repaired?
What is the diagnosis and treatment for Complex Regional Pain Syndrome (CRPS)?
What are the recommended shoes for Complex Regional Pain Syndrome (CRPS)?
What does a calcium level of 10.4 and a PTH (Parathyroid Hormone) level of 40 indicate in a patient?
What is the best management approach for a 32-year-old male with a history of horseshoe kidney and hereditary hemochromatosis (HH) DNA mutation, presenting with iron overload, elevated ferritin, and hypercalcemia?
Where should the tip of a peritoneal (peritoneal dialysis) catheter be placed in a patient undergoing peritoneal dialysis or intraperitoneal chemotherapy?
What is the best course of action for a 50-year-old female patient with schizoaffective bipolar type, who has a history of gastrointestinal upset with oral antipsychotics, including Abilify (Aripiprazole), Olanzapine, and Quetiapine, and is now experiencing hyperprolactinemia-induced breast milk production while on Paliperidone (Invega) 9mg and Paliperidone Palmitate (Invega Sustenna) injections, despite the medication regimen being effective in managing her symptoms?
What is the equivalent dose of olmesartan (Angiotensin II receptor antagonist) for a patient taking irbesartan (Angiotensin II receptor antagonist) 300mg?
What is the recommended treatment approach for an adult patient with a history of depression using Auvelity (dextromethadone/bupropion)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.